ET-523

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameET-523
Drug Alias NameET-523
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunoglobulin E modulatorsImmunoglobulin epsilon Fc receptor modulators
TargetsImmunoglobulin epsilon Fc receptorImmunoglobulin E
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpsilon Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpsilon TherapeuticsBoston University
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A